EFFECTIVENESS OF ORAL ISOTRETINOIN VERSUS TOPICAL TRETINOIN 0.05% IN THE MANAGEMENT OF FACIAL PLANE WARTS
DOI:
https://doi.org/10.55519/JAMC-02-13087Keywords:
Facial warts; Plane warts; Isotretinoin; Verruca plana; TretinoinAbstract
Background: Facial plane warts present a therapeutic challenge due to limited treatment options. Electrocautery and cryotherapy, though effective, carry risks of scarring and pigmentation. LASER therapy is often inaccessible in resource-limited settings. While both topical tretinoin and oral isotretinoin have shown satisfactory outcomes, no standard treatment exists. Dermatologists are cautious with oral isotretinoin due to the absence of clear guidelines. This trial aimed to compare the efficacy of oral isotretinoin versus topical tretinoin 0.05% in treating facial plane warts. Methods: Approved by the hospital’s ethics board, the study began in January 2023 at Khyber Teaching Hospital. Clinically diagnosed patients with facial and neck plane warts were enrolled. A total of 106 participants were randomized into two groups. Group A received topical tretinoin 0.05%, while Group B was administered oral isotretinoin at 0.5 mg/kg. Treatment response was assessed at 1 and 3 months. Complete lesion clearance marked treatment success, with monthly follow-up for 3 months to assess recurrence. Results: Among 106 patients (61 males, 45 females), 30 (56.6%) in Group A and 42 (79.2%) in Group B achieved complete clearance (p=0.0125). Recurrence occurred in 4 participants per group (13.3% in A; 9.3% in B, p=0.612). Conclusion: Oral isotretinoin proved significantly more effective than topical tretinoin 0.05% in treating facial plane warts, with a comparable recurrence rate.
References
1. Ghadgepatil SS, Gupta S, Sharma YK. Clinicoepidemiological Study of Different Types of Warts. Dermatol Res Prac 2016;2016(2):1–4.
2. Zhu P, Qi RQ, Yang Y, Hou W, Zhang Y, He L, et al. Clinical guideline for the diagnosis and treatment of cutaneous warts (2022). J Evid Based Med 2022;15(3):284–301.
3. Truong K, Joseph J, Manago B, Wain T. Destructive therapies for cutaneous warts: A review of the evidence. Aust J Gen Pract 2022;51(10):799–803.
4. Sterling JC, Gibbs S, Haque Hussain SS, Mohd Mustapa MF, Handfield-Jones SE, Hughes JR, et al. British Association of Dermatologists’ guidelines for the management of cutaneous warts 2014. Br J Dermatol 2014;171(4):696–712.
5. Le M, Conte S, Hsu JT, Li MK. 44491 Laser and Energy-Based Devices for the Treatment of Cutaneous Verrucae: A Systematic Review. J Am Acad Dermatol 2023;89(3):AB186–6.
6. Gerlero P, Hernández-Martín Á. Treatment of warts in children: an update. Actas Dermosifiliogr Engl Ed 2016;107(7):551–8.
7. Kaur GJ, Brar BK, Kumar S, Brar SK, Singh B. Evaluation of the efficacy and safety of oral isotretinoin versus topical isotretinoin in the treatment of plane warts: a randomized open trial. Int J Dermatol 2017;56(12):1352–8.
8. Sivasankari M, Adityan MS. Oral isotretinoin as first-line systemic therapy in a case of extensive genital warts. Indian J Sex Transm Dis AIDS 2022;43(1):70–2.
9. Singh R, Pandey SS. Efficacy of Topical 5% 5-Fluorouracil and 0.05% Tretinoin and Electrosurgery in the Treatment of Plane Warts: A Randomized Controlled Comparative Trial. Nepal J Dermatol Venereol Leprol 2021 2024;19(1):55–9.
10. Gaston A, Garry RF. Topical vitamin A treatment of recalcitrant common warts. Virol J 2012;9(1):21.
11. Gupta M. Adapalene in the Management of Warts in Pediatric Population. Indian J Paediatr Dermatol 2019;20(1):29–31.
12. Nooruldeen AD, Saeed MY. Efficacy and safety of oral isotretinoin in treatment of plane warts. Bali Med J 2021;10(3):1076–80.
13. Kubeyinje EP. Evaluation of the efficacy and safety of 0.05% tretinoin cream in the treatment of plane warts in Arab children. J Dermatol Treat 1996;7(1):21–2.
14. Nofal A, Abdel Shafy A, Najah S. An overview of role of retinoids in management of warts: review article. Egypt J Hosp Med 2022;86(1):641–4.
15. Akkam A, Husam AS, Aws JH. Treatment of Facial Plane Warts, a Comparative Study of Topical 5% KOH Solution with Topical 0.05% Tretinoin Cream. Iraqi J Community Med 2018;31(3):122–7.
16. Białecka A, Męcińska-Jundziłł K, Adamska U, Cichewicz A, Białecki M, Drewa G, et al. Plane warts on the back of the hand successfully treated with oral isotretinoin. Adv Dermatol Alergol 2018;35(2):227–9.
17. Kosumi H, Natsuga K, Yanagi T, Ujiie H. Systemic retinoids for generalized verrucosis due to congenital immunodeficiency: case reports and review of the literature. Genes 2023;14(3):769–9.
18. Pasmatzi E, Badavanis G, Kapranos N, Apostolidou A, Monastirli A, Tsambaos D. Extensive and recalcitrant common warts in an immunocompetent patient: rapid and complete remission after oral isotretinoin monotherapy. Acta Dermatovenerol Alp Pannonica Adriat 2020;29(1):35–7.
19. Dave DD, Abdelmaksoud A. Low dose isotretinoin as an adjuvant therapy for treatment of different clinical variants of warts: A case series. Dermatol Ther 2019;32(2):e12836.
20. Olguin-García MG, Jurado-Santa Cruz F, Peralta-Pedrero ML, Morales-Sánchez MA. A double-blind, randomized, placebo-controlled trial of oral isotretinoin in the treatment of recalcitrant facial flat warts. J Dermatol Treat 2015;26(1):78–82.
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Huma Gul, Jahangir Khan, Zarar Bin Jamil
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.
